WEINGARTEN ROBERT N 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Nov 9, 2022
Insider Transaction Report
Form 4
WEINGARTEN ROBERT N
Vice President and CFO
Transactions
- Award
Stock Options
2022-11-06+200,000→ 200,000 totalExercise: $2.00From: 2022-11-06Exp: 2027-11-06→ Common (200,000 underlying)
Holdings
- 58,333
Stock Options
Exercise: $7.14From: 2020-08-12Exp: 2025-08-12→ Common (58,333 underlying)
Footnotes (1)
- [F1]On November 6, 2022, the reporting person was granted options to purchase 200,000 shares of the issuer's common stock, exercisable for a period of 5 years at $2.00 per share, vesting 25% on the issuance date, and 25% on each anniversary date thereafter until fully vested, subject to continued service.